Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Choroidal Neovascularization CNV Market Report 2016

  • QYR781870
  • 98 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Choroidal Neovascularization (CNV)

Revenue, means the sales value of Choroidal Neovascularization (CNV)

This report studies sales (consumption) of Choroidal Neovascularization (CNV) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer Inc.

F. Hoffmann-La Roche Ltd.

Novartis AG

Regeneron Pharmaceuticals Inc.

Bayer AG

QLT Inc.

Sanwa Kagaku Kenkyusho Co. Ltd.

Promedior Inc.

Valeant Pharmaceuticals International Inc.

Gilead Sciences

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Choroidal Neovascularization (CNV) in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Choroidal Neovascularization (CNV) Market Report 2016

1 Choroidal Neovascularization (CNV) Overview

1.1 Product Overview and Scope of Choroidal Neovascularization (CNV)

1.2 Classification of Choroidal Neovascularization (CNV)

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Choroidal Neovascularization (CNV)

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Choroidal Neovascularization (CNV) (2011-2021)

1.4.1 United States Choroidal Neovascularization (CNV) Sales and Growth Rate (2011-2021)

1.4.2 United States Choroidal Neovascularization (CNV) Revenue and Growth Rate (2011-2021)

2 United States Choroidal Neovascularization (CNV) Competition by Manufacturers

2.1 United States Choroidal Neovascularization (CNV) Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Choroidal Neovascularization (CNV) Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Choroidal Neovascularization (CNV) Average Price by Manufactures (2015 and 2016)

2.4 Choroidal Neovascularization (CNV) Market Competitive Situation and Trends

2.4.1 Choroidal Neovascularization (CNV) Market Concentration Rate

2.4.2 Choroidal Neovascularization (CNV) Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Choroidal Neovascularization (CNV) Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Choroidal Neovascularization (CNV) Sales and Market Share by Type (2011-2016)

3.2 United States Choroidal Neovascularization (CNV) Revenue and Market Share by Type (2011-2016)

3.3 United States Choroidal Neovascularization (CNV) Price by Type (2011-2016)

3.4 United States Choroidal Neovascularization (CNV) Sales Growth Rate by Type (2011-2016)

4 United States Choroidal Neovascularization (CNV) Sales (Volume) by Application (2011-2016)

4.1 United States Choroidal Neovascularization (CNV) Sales and Market Share by Application (2011-2016)

4.2 United States Choroidal Neovascularization (CNV) Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Choroidal Neovascularization (CNV) Manufacturers Profiles/Analysis

5.1 Pfizer Inc.

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 F. Hoffmann-La Roche Ltd.

5.2.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Novartis AG

5.3.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Novartis AG Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Regeneron Pharmaceuticals Inc.

5.4.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Bayer AG

5.5.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Bayer AG Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 QLT Inc.

5.6.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 QLT Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sanwa Kagaku Kenkyusho Co. Ltd.

5.7.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Promedior Inc.

5.8.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Promedior Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Valeant Pharmaceuticals International Inc.

5.9.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Valeant Pharmaceuticals International Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Gilead Sciences

5.10.2 Choroidal Neovascularization (CNV) Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Gilead Sciences Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

6 Choroidal Neovascularization (CNV) Manufacturing Cost Analysis

6.1 Choroidal Neovascularization (CNV) Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Choroidal Neovascularization (CNV)

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Choroidal Neovascularization (CNV) Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Choroidal Neovascularization (CNV) Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Choroidal Neovascularization (CNV) Market Forecast (2016-2021)

10.1 United States Choroidal Neovascularization (CNV) Sales, Revenue Forecast (2016-2021)

10.2 United States Choroidal Neovascularization (CNV) Sales Forecast by Type (2016-2021)

10.3 United States Choroidal Neovascularization (CNV) Sales Forecast by Application (2016-2021)

10.4 Choroidal Neovascularization (CNV) Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Choroidal Neovascularization (CNV)

Table Classification of Choroidal Neovascularization (CNV)

Figure United States Sales Market Share of Choroidal Neovascularization (CNV) by Type in 2015

Table Application of Choroidal Neovascularization (CNV)

Figure United States Sales Market Share of Choroidal Neovascularization (CNV) by Application in 2015

Figure United States Choroidal Neovascularization (CNV) Sales and Growth Rate (2011-2021)

Figure United States Choroidal Neovascularization (CNV) Revenue and Growth Rate (2011-2021)

Table United States Choroidal Neovascularization (CNV) Sales of Key Manufacturers (2015 and 2016)

Table United States Choroidal Neovascularization (CNV) Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Choroidal Neovascularization (CNV) Sales Share by Manufacturers

Figure 2016 Choroidal Neovascularization (CNV) Sales Share by Manufacturers

Table United States Choroidal Neovascularization (CNV) Revenue by Manufacturers (2015 and 2016)

Table United States Choroidal Neovascularization (CNV) Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Choroidal Neovascularization (CNV) Revenue Share by Manufacturers

Table 2016 United States Choroidal Neovascularization (CNV) Revenue Share by Manufacturers

Table United States Market Choroidal Neovascularization (CNV) Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Choroidal Neovascularization (CNV) Average Price of Key Manufacturers in 2015

Figure Choroidal Neovascularization (CNV) Market Share of Top 3 Manufacturers

Figure Choroidal Neovascularization (CNV) Market Share of Top 5 Manufacturers

Table United States Choroidal Neovascularization (CNV) Sales by Type (2011-2016)

Table United States Choroidal Neovascularization (CNV) Sales Share by Type (2011-2016)

Figure United States Choroidal Neovascularization (CNV) Sales Market Share by Type in 2015

Table United States Choroidal Neovascularization (CNV) Revenue and Market Share by Type (2011-2016)

Table United States Choroidal Neovascularization (CNV) Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Choroidal Neovascularization (CNV) by Type (2011-2016)

Table United States Choroidal Neovascularization (CNV) Price by Type (2011-2016)

Figure United States Choroidal Neovascularization (CNV) Sales Growth Rate by Type (2011-2016)

Table United States Choroidal Neovascularization (CNV) Sales by Application (2011-2016)

Table United States Choroidal Neovascularization (CNV) Sales Market Share by Application (2011-2016)

Figure United States Choroidal Neovascularization (CNV) Sales Market Share by Application in 2015

Table United States Choroidal Neovascularization (CNV) Sales Growth Rate by Application (2011-2016)

Figure United States Choroidal Neovascularization (CNV) Sales Growth Rate by Application (2011-2016)

Table Pfizer Inc. Basic Information List

Table Pfizer Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. Basic Information List

Table F. Hoffmann-La Roche Ltd. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Novartis AG Basic Information List

Table Novartis AG Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis AG Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Regeneron Pharmaceuticals Inc. Basic Information List

Table Regeneron Pharmaceuticals Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Regeneron Pharmaceuticals Inc. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Bayer AG Basic Information List

Table Bayer AG Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer AG Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table QLT Inc. Basic Information List

Table QLT Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table QLT Inc. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Sanwa Kagaku Kenkyusho Co. Ltd. Basic Information List

Table Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Promedior Inc. Basic Information List

Table Promedior Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Promedior Inc. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Valeant Pharmaceuticals International Inc. Basic Information List

Table Valeant Pharmaceuticals International Inc. Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Valeant Pharmaceuticals International Inc. Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Gilead Sciences Basic Information List

Table Gilead Sciences Choroidal Neovascularization (CNV) Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gilead Sciences Choroidal Neovascularization (CNV) Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Choroidal Neovascularization (CNV)

Figure Manufacturing Process Analysis of Choroidal Neovascularization (CNV)

Figure Choroidal Neovascularization (CNV) Industrial Chain Analysis

Table Raw Materials Sources of Choroidal Neovascularization (CNV) Major Manufacturers in 2015

Table Major Buyers of Choroidal Neovascularization (CNV)

Table Distributors/Traders List

Figure United States Choroidal Neovascularization (CNV) Production and Growth Rate Forecast (2016-2021)

Figure United States Choroidal Neovascularization (CNV) Revenue and Growth Rate Forecast (2016-2021)

Table United States Choroidal Neovascularization (CNV) Production Forecast by Type (2016-2021)

Table United States Choroidal Neovascularization (CNV) Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370